Details of the Drug Formulations

General Information of Drug (ID: DMD2WPG)

• Drug Name: TRIENTINE Drug Info
• Synonyms: Trientine HCl; 21121-06-2; triethylenetetramine HCl; SMR000058543; AC1NUQ0M; MLS000069683; SCHEMBL205201; CHEMBL1200783; CTK0I9735; DTXSID80419994; XPVOJYDIBHYVFL-UHFFFAOYSA-N; Pharmakon1600-01505675; NSC759164; NSC158271; AKOS027276425; NSC-158271; NSC-759164; 1, N,N'-bis(2-aminoethyl)-, tetrahydrochloride; 1,2-Ethanediamine, N,N'-bis(2-aminoethyl)-, hydrochloride; N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine hydrochloride

Indication

Disease Entry	ICD 11	Status	REF
Inborn error of metabolism	5C50-5C59	Approved	[1]
Wilson disease	5C64.00	Investigative	[2]

• Cross-matching ID:
  PubChem CID: 5565
  ChEBI ID: CHEBI:39501
  CAS Number: 112-24-3
  TTD ID: D09VAZ
  ACDINA ID: D00702

Full List of Drug Formulations Containing This Drug

Trientine 250 mg capsule

Company	Formulation ID	FDA Description
Aton Pharma	F21665	Stearic acid; Titanium dioxide; Gelatin
Valeant Pharmaceuticals	F21666	Stearic acid; Titanium dioxide; Gelatin

Trientine Hydrochloride 250mg capsule

Company	Formulation ID	FDA Description
Kadmon Pharmaceuticals	F23591	Stearic Acid; Gelatin; Titanium Dioxide; Shellac; Titanium Dioxide; Fd&C Yellow 5 Aluminum Lake; Fd&C Blue 1 Aluminum Lake; Fd&C Blue 2/Indigo Carmine Aluminum Lake; Fd&C Blue 1/Brilliant Blue Fcf Aluminum Lake
Oceanside Pharmaceutials	F23589	Gelatin; Iron Oxides; Stearic Acid; Titanium Dioxide
Navinta	F23590	Shellac; Propylene Glycol; Black Iron Oxide; Potassium Hydroxide

References

• [1] Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015
• [2] Trientine FDA Label